Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy
- 1 January 1997
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 145 (1), 109-112
- https://doi.org/10.1016/s0022-510x(96)00256-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Competitive binding enzyme immunoassay for zonisamide, a new antiepileptic drug, with selected paired-enzyme labeled antigen and antibodyClinical Chemistry, 1990
- A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.British Journal of Clinical Pharmacology, 1984
- Polarisation fluoroimmunoassay of phenytoinClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- Phenytoin and folate deficiency: Failure to show dose dependencyZeitschrift für Neurologie, 1974
- ANTICONVULSANTS, FOLIC ACID, AND EPILEPSYThe Lancet, 1973
- Folate Deficiency after Anticonvulsant Drugs: An Effect of Hepatic Enzyme Induction?BMJ, 1972
- Folic Acid and Anticonvulsive DrugsArchives of Neurology, 1969
- STUDIES ON DEFICIENCY AND ABSORPTION OF FOLATES IN PATIENTS ON ANTICONVULSANT DRUGSAustralasian Annals of Medicine, 1967
- Serum Folic-acid and Vitamin-B12 Levels in Anticonvulsant TherapyBMJ, 1966
- Megaloblastic Anaemia Occurring During Primidone TherapyBMJ, 1956